300 related articles for article (PubMed ID: 25294759)
1. [AGEs and RAGE - advanced glycation end-products and their receptor in questions and answers].
Kalousová M; Zima T
Vnitr Lek; 2014 Sep; 60(9):720-4. PubMed ID: 25294759
[TBL] [Abstract][Full Text] [Related]
2. Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives.
Khalid M; Petroianu G; Adem A
Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454131
[TBL] [Abstract][Full Text] [Related]
3. Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis.
Leung SS; Forbes JM; Borg DJ
Curr Diab Rep; 2016 Oct; 16(10):100. PubMed ID: 27612847
[TBL] [Abstract][Full Text] [Related]
4. Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions.
Neviere R; Yu Y; Wang L; Tessier F; Boulanger E
Glycoconj J; 2016 Aug; 33(4):607-17. PubMed ID: 27277623
[TBL] [Abstract][Full Text] [Related]
5. Understanding RAGE, the receptor for advanced glycation end products.
Bierhaus A; Humpert PM; Morcos M; Wendt T; Chavakis T; Arnold B; Stern DM; Nawroth PP
J Mol Med (Berl); 2005 Nov; 83(11):876-86. PubMed ID: 16133426
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease.
Prasad K; Tiwari S
Curr Pharm Des; 2017; 23(6):937-943. PubMed ID: 27719648
[TBL] [Abstract][Full Text] [Related]
7. Targeting receptors of advanced glycation end products (RAGE): Preventing diabetes induced cancer and diabetic complications.
Chhipa AS; Borse SP; Baksi R; Lalotra S; Nivsarkar M
Pathol Res Pract; 2019 Nov; 215(11):152643. PubMed ID: 31564569
[TBL] [Abstract][Full Text] [Related]
8. Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions.
Koerich S; Parreira GM; de Almeida DL; Vieira RP; de Oliveira ACP
Curr Neuropharmacol; 2023; 21(2):219-234. PubMed ID: 36154605
[TBL] [Abstract][Full Text] [Related]
9. Role of advanced glycation end product (AGE)-induced receptor (RAGE) expression in diabetic vascular complications.
Chawla D; Bansal S; Banerjee BD; Madhu SV; Kalra OP; Tripathi AK
Microvasc Res; 2014 Sep; 95():1-6. PubMed ID: 24984291
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications.
Yan SF; Ramasamy R; Schmidt AM
Nat Clin Pract Endocrinol Metab; 2008 May; 4(5):285-93. PubMed ID: 18332897
[TBL] [Abstract][Full Text] [Related]
11. Receptor for Advanced Glycation End Products Acts as a Fuel to Colorectal Cancer Development.
Azizian-Farsani F; Abedpoor N; Hasan Sheikhha M; Gure AO; Nasr-Esfahani MH; Ghaedi K
Front Oncol; 2020; 10():552283. PubMed ID: 33117687
[TBL] [Abstract][Full Text] [Related]
12. Polyol pathway and RAGE: a central metabolic and signaling axis in diabetic complications.
Ramasamy R; Yan SF; Schmidt AM
Expert Rev Endocrinol Metab; 2010 Jan; 5(1):65-75. PubMed ID: 30934384
[TBL] [Abstract][Full Text] [Related]
13. Low glucose degradation product peritoneal dialysis regimen is associated with lower plasma EN-RAGE and HMGB-1 proinflammatory ligands of receptor for advanced glycation end products.
Opatrna S; Popperlova A; Kalousová M; Zima T
Ther Apher Dial; 2014 Jun; 18(3):309-16. PubMed ID: 24965297
[TBL] [Abstract][Full Text] [Related]
14. Blockade of the advanced glycation end products (AGEs) and their receptor (RAGE) system is a possible mechanism for sustained beneficial effects of multifactorial intervention on mortality in type 2 diabetes.
Yamagishi S; Matsui T; Nakamura K
Med Hypotheses; 2008 Nov; 71(5):749-51. PubMed ID: 18710793
[TBL] [Abstract][Full Text] [Related]
15. Receptor for advanced glycation end products (RAGE) in vascular and inflammatory diseases.
Mahajan N; Dhawan V
Int J Cardiol; 2013 Oct; 168(3):1788-94. PubMed ID: 23722052
[TBL] [Abstract][Full Text] [Related]
16. The protective effect of Smilax glabra extract on advanced glycation end products-induced endothelial dysfunction in HUVECs via RAGE-ERK1/2-NF-κB pathway.
Sang HQ; Gu JF; Yuan JR; Zhang MH; Jia XB; Feng L
J Ethnopharmacol; 2014 Aug; 155(1):785-95. PubMed ID: 24953033
[TBL] [Abstract][Full Text] [Related]
17. [Role of the receptor for advanced glycation end products (RAGE) in inflammation].
Mosquera JA
Invest Clin; 2010 Jun; 51(2):257-68. PubMed ID: 20928981
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycation end-products induced VEGF production and inflammatory responses in human synoviocytes via RAGE-NF-κB pathway activation.
Chen YJ; Chan DC; Chiang CK; Wang CC; Yang TH; Lan KC; Chao SC; Tsai KS; Yang RS; Liu SH
J Orthop Res; 2016 May; 34(5):791-800. PubMed ID: 26497299
[TBL] [Abstract][Full Text] [Related]
19. AGEs, RAGEs and s-RAGE; friend or foe for cancer.
Ahmad S; Khan H; Siddiqui Z; Khan MY; Rehman S; Shahab U; Godovikova T; Silnikov V; Moinuddin
Semin Cancer Biol; 2018 Apr; 49():44-55. PubMed ID: 28712719
[TBL] [Abstract][Full Text] [Related]
20. The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease.
Yan SF; Ramasamy R; Schmidt AM
Expert Rev Mol Med; 2009 Mar; 11():e9. PubMed ID: 19278572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]